Yuhan Corp Preferred (000105) - Total Assets
Based on the latest financial reports, Yuhan Corp Preferred (000105) holds total assets worth ₩3.28 Trillion KRW (≈ $2.22 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Yuhan Corp Preferred - Total Assets Trend (2014–2025)
This chart illustrates how Yuhan Corp Preferred's total assets have evolved over time, based on quarterly financial data. Also see Yuhan Corp Preferred (000105) total market value for the company's overall valuation and market capitalisation.
Yuhan Corp Preferred - Asset Composition Analysis
Current Asset Composition (December 2025)
Yuhan Corp Preferred's total assets of ₩3.28 Trillion consist of 46.9% current assets and 53.1% non-current assets. Review Yuhan Corp Preferred balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 10.8% |
| Accounts Receivable | ₩694.44 Billion | 21.6% |
| Inventory | ₩372.76 Billion | 11.6% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩184.67 Billion | 5.7% |
| Goodwill | ₩115.07 Billion | 3.6% |
Asset Composition Trend (2014–2025)
This chart illustrates how Yuhan Corp Preferred's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Yuhan Corp Preferred stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yuhan Corp Preferred's current assets represent 46.9% of total assets in 2025, a decrease from 52.1% in 2014.
- Cash Position: Cash and equivalents constituted 10.8% of total assets in 2025, up from 9.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 21.6% of total assets.
Yuhan Corp Preferred Competitors by Total Assets
Key competitors of Yuhan Corp Preferred based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
|
China | CN¥4.49 Billion |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
USA | $199.45 Million |
Yuhan Corp Preferred - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.03 | 2.06 | 2.71 |
| Quick Ratio | 1.48 | 1.50 | 2.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩812.79 Billion | ₩733.03 Billion | ₩807.20 Billion |
Yuhan Corp Preferred - Advanced Valuation Insights
This section examines the relationship between Yuhan Corp Preferred's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.96 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 9.5% |
| Total Assets | ₩3.22 Trillion |
| Market Capitalization | $45.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Yuhan Corp Preferred's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Yuhan Corp Preferred's assets grew by 9.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Yuhan Corp Preferred (2014–2025)
The table below shows the annual total assets of Yuhan Corp Preferred from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩3.22 Trillion ≈ $2.18 Billion |
+9.48% |
| 2024-12-31 | ₩2.94 Trillion ≈ $1.99 Billion |
+22.43% |
| 2023-12-31 | ₩2.40 Trillion ≈ $1.63 Billion |
-2.82% |
| 2022-12-31 | ₩2.47 Trillion ≈ $1.68 Billion |
+0.36% |
| 2021-12-31 | ₩2.46 Trillion ≈ $1.67 Billion |
+2.94% |
| 2020-12-31 | ₩2.39 Trillion ≈ $1.62 Billion |
+13.05% |
| 2019-12-31 | ₩2.12 Trillion ≈ $1.43 Billion |
-2.60% |
| 2018-12-31 | ₩2.17 Trillion ≈ $1.47 Billion |
+3.78% |
| 2017-12-31 | ₩2.09 Trillion ≈ $1.42 Billion |
+2.38% |
| 2016-12-31 | ₩2.05 Trillion ≈ $1.39 Billion |
+8.81% |
| 2015-12-31 | ₩1.88 Trillion ≈ $1.27 Billion |
+16.36% |
| 2014-12-31 | ₩1.62 Trillion ≈ $1.10 Billion |
-- |
About Yuhan Corp Preferred
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more